Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|August 12, 2005
Comparison of the severity of bilateral Le Fort injuries in isolated midface traumaShahrokh C Bagheri, Eric Holmgren, Deepak Kademani, et al.Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|February 21, 2006
Application of a facial injury severity scale in craniomaxillofacial traumaShahrokh C Bagheri, Eric J Dierks, Deepak Kademani, et al.Langmuir : the ACS Journal of Surfaces and Colloids|December 14, 2016
Chemical Identification at the Solid-Liquid InterfaceHagen Söngen, Christoph Marutschke, Peter Spijker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancerHerbert I Hurwitz, Louis Fehrenbacher, John D Hainsworth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2005
Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomasMarkus Bredel, Claudia Bredel, Dejan Juric, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trialsStuart D Russell, Kimberly L Blackwell, Julia Lawrence, et al.Journal of the National Cancer Institute|August 10, 2007
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumabFrank A Scappaticci, Jamey R Skillings, Scott N Holden, et al.Future Oncology (London, England)|September 28, 2020
A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphomaMartin Dreyling, Constantine S Tam, Michael Wang, et al.The New England Journal of Medicine|June 4, 2004
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancerHerbert Hurwitz, Louis Fehrenbacher, William Novotny, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancerDavid H Johnson, Louis Fehrenbacher, William F Novotny, et al.Pageof 3